REQUEST A DEMO
Total
USD $0.00
Search more companies

Amicogen Inc. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Amicogen Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Amicogen, Inc is a bio-company that develops industrial and pharmaceutical special enzymes using its own DNA evolution technology. Amicogen aims for sustainable growth through innovative technologies and products, including special-efficient, healthcare, and protein-regulating solutions. The company positions itself as a biotechnology company with a focus on creating new values.

Headquarters
64, Dongburo 1259-Gil, Jinseong-Myeon,Jinju
Jinju; Gyeongsangnam; Postal Code: 660-852

Contact Details: Purchase the Amicogen Inc. report to view the information.

Website: http://www.amicogen.com

Basic Information
Total Employees:
Purchase the Amicogen Inc. report to view the information.
Outstanding Shares:
Purchase the Amicogen Inc. report to view the information.
Registered Capital:
Purchase the Amicogen Inc. report to view the information.
Financial Auditors:
Purchase the Amicogen Inc. report to view the information.
Incorporation Date:
May 29, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
18.45%
Purchase this report to view the information.
1.12%
Purchase this report to view the information.
0.43%
Purchase this report to view the information.
0.41%
Subsidiaries
(주)비엔티에스
(주)스킨메드
(주)아미코젠파마
Company Performance
Financial values in the chart are available after Amicogen Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-72.72%
Total Operating Revenue
-68.75%
Operating Profit
35.91%
EBITDA
26.59%
Net Profit/Loss for the Period
17.06%
Total Assets
-47.79%
Total Equity
-48.47%
Operating Profit Margin
-18.17%
Net Profit Margin
-37.81%
Return on Equity (ROE)
-4.07%
Debt / Equity
31636%
Quick Ratio
-32.18%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?